Cognitive impairment occurs frequently after surgery in the approximately 400,000 patients who undergo cardiac operations each year. An increasing number of these patients are elderly, and we have found that this patient population is particularly susceptible to cognitive dysfunction after cardiac surgery. Cognitive impairment is most notable in the early phases after cardiac surgery, but persistence occurs in an important percentage of patients. While adjectives such as """"""""subtle,"""""""" """"""""transient,"""""""" and """"""""subclinical"""""""" have been used due to the apparent transient nature of decline, we have identified that perioperative decline is associated with five year cognitive deterioration and reduced quality of life. Multiple strategies, both clinical and pharmacological, have been proposed to reduce the central nervous system dysfunction associated with cardiac surgery. However, most have been unsuccessful, met with very limited success, or are unrealistic from a cost or risk-benefit ratio to be applied to the majority of patients. We will test the ability of supplemental magnesium, achieving plasma levels 2x normal, to provide protection from neurocognitive decline in patients undergoing cardiac surgery. This clinical trial will enroll 400 patients over approximately 48 months. A battery of neurocognitive tests as well as a neurologic assessment will be completed at baseline, discharge, 4 - 6 weeks, and one year postoperatively. Our multidisciplinary research team has extensive experience in assessing neurocognitive decline both short and long-term after cardiac surgery, will allow this project to be accomplished expeditiously both as a pilot clinical and following efficacy trial. Multiple animal studies demonstrate a benefit of magnesium in focal and global models of ischemia. Although still early in enrollment, the Interventional magnesium stroke study (IMAGES) has yielded promising results. Little is more devastating to a patient, the patient's family or those caring for a patient than to have a successful operation that prolongs life, but diminishes the quality of that prolonged life. Nothing is more likely to adversely impact the quality of life than deterioration in a patient?s mental status, particularly those higher faculties that we call cognition. Therefore, we will also determine if magnesium bolus plus infusion given perioperatively can improve quality of life through improved cognitive performance. We propose that magnesium, through one of a number of potential mechanisms will allow us to alter susceptibility to neurocognitive dysfunction and thereby prevent this tragic consequence in the aging population.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL069081-01
Application #
6422798
Study Section
Special Emphasis Panel (ZRG1-RPHB-3 (01))
Program Officer
Jobe, Jared B
Project Start
2001-12-01
Project End
2005-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
1
Fiscal Year
2002
Total Cost
$552,597
Indirect Cost
Name
Duke University
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Kertai, Miklos D; Qi, Wenjing; Li, Yi-Ju et al. (2016) Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving ?-blockers. J Mol Cell Cardiol 92:109-15
Bartels, Karsten; Li, Yi-Ju; Li, Yen-Wei et al. (2015) Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery: a retrospective cohort study. Can J Anaesth 62:618-26
Kertai, Miklos D; Li, Yi-Ju; Ji, Yunqi et al. (2015) Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery. Am Heart J 170:580-90.e28
Stafford-Smith, Mark; Li, Yi-Ju; Mathew, Joseph P et al. (2015) Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci. Kidney Int 88:823-32
Klinger, Rebecca Y; Thunberg, Christopher A; White, William D et al. (2015) Intraoperative Magnesium Administration Does Not Reduce Postoperative Atrial Fibrillation After Cardiac Surgery. Anesth Analg 121:861-7
Kertai, Miklos D; Li, Yen-Wei; Li, Yi-Ju et al. (2014) G protein-coupled receptor kinase 5 gene polymorphisms are associated with postoperative atrial fibrillation after coronary artery bypass grafting in patients receiving ?-blockers. Circ Cardiovasc Genet 7:625-633
Fontes, Monique T; McDonagh, David L; Phillips-Bute, Barbara et al. (2014) Arterial hyperoxia during cardiopulmonary bypass and postoperative cognitive dysfunction. J Cardiothorac Vasc Anesth 28:462-6
Fontes, Monique T; Swift, R Cameron; Phillips-Bute, Barbara et al. (2013) Predictors of cognitive recovery after cardiac surgery. Anesth Analg 116:435-42
Mathew, Joseph P; White, William D; Schinderle, David B et al. (2013) Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. Stroke 44:3407-13
Nikolov, Nikolay M; Fontes, Manuel L; White, William D et al. (2010) Pulse pressure and long-term survival after coronary artery bypass graft surgery. Anesth Analg 110:335-40